Betazolo [Dcit] en es it fr

Betazolo [Dcit] Brand names, Betazolo [Dcit] Analogs

Betazolo [Dcit] Brand Names Mixture

  • No information avaliable

Betazolo [Dcit] Chemical_Formula

C5H9N3

Betazolo [Dcit] RX_link

No information avaliable

Betazolo [Dcit] fda sheet

Betazolo [Dcit] msds (material safety sheet)

Betazolo [Dcit] Synthesis Reference

No information avaliable

Betazolo [Dcit] Molecular Weight

111.145 g/mol

Betazolo [Dcit] Melting Point

< 25 oC

Betazolo [Dcit] H2O Solubility

No information avaliable

Betazolo [Dcit] State

Liquid

Betazolo [Dcit] LogP

0.069

Betazolo [Dcit] Dosage Forms

Injection

Betazolo [Dcit] Indication

For use clinically to test gastric secretory function.

Betazolo [Dcit] Pharmacology

Betazole is a histamine H2 agonist used in a test for measuring maximal production of gastric acidity or anacidity. This measurement can be used to diagnose diseases such as Zollinger-Ellison syndrome, whereby the volume of gastric and basal secretions is measured following betazole administration (greater than 60% of the maximal acid secretion following betazole stimulation). In another test, gastritis can be diagnosed given late absence of gastric acid which is unresponsive to betazole stimulation. Betazole can be used as a gastric secretory stimulant instead of histamine with the advantage of not provoking side effects and thus not requiring the use of antihistaminic compounds.

Betazolo [Dcit] Absorption

Rapid and complete.

Betazolo [Dcit] side effects and Toxicity

No information avaliable

Betazolo [Dcit] Patient Information

No information avaliable

Betazolo [Dcit] Organisms Affected

Humans and other mammals